BR0212679A - Inhibition of exoprotein production using aromatic compositions - Google Patents

Inhibition of exoprotein production using aromatic compositions

Info

Publication number
BR0212679A
BR0212679A BR0212679-6A BR0212679A BR0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A
Authority
BR
Brazil
Prior art keywords
unsaturated aliphatic
aliphatic hydrocarbyl
hydrocarbyl moiety
saturated
aromatic
Prior art date
Application number
BR0212679-6A
Other languages
Portuguese (pt)
Inventor
Rae Ellen Syverson
Richard A Proctor
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR0212679A publication Critical patent/BR0212679A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Abstract

"INIBIçãO DE PRODUçãO DE EXOPROTEìNA USANDO COMPOSIçõES AROMáTICAS". Artigos absorventes e não absorventes são mostrados. os artigos incluem uma quantidade efetiva de um composto inibidor aromático para inibir substancialmente a produção de exotoxinas por bactérias Gram-positivas. Os compostos inibidores aromáticos da presente invenção têm a fórmula geral (I), onde R^ 1^ é selecionado a partir do grupo que consiste em H, (a), OR^ 5^, -R^ 6^C(O)H, -R^ 6^OH, -R^ 6^COOH, -OR^ 6^OH, -OR^ 6^COOH, -C(O)NH~ 2~, fórmula (1) e NH~ 2~ e sais do mesmo; R^ 5^ é uma porção hidrocarbila alifática saturada ou insaturada monovalente; R^ 6^ é uma porção hidrocarbila alifática saturada ou insaturada divalente; R^ 7^ é uma porção hidrocarbila alifática saturada ou insaturada trivalente; R^ 8^ é uma porção hidrocarbila alifática saturada ou insaturada substituída ou não substituída monovalente, a qual pode ou não ser interrompida com heteroátomos; R^ 2^, R^ 3^ e R^ 4^ são independentemente selecionados a partir do grupo que consiste em H, OH, COOH, e -C (O) R^ 9^; R^ 9^ é hidrogênio ou uma porção hidrocarbila alifática saturada ou insaturada monovalente."EXOPROTEIN PRODUCTION INHIBITION USING AROMATIC COMPOSITIONS". Absorbent and non-absorbent articles are shown. The articles include an effective amount of an aromatic inhibitor compound to substantially inhibit exotoxin production by Gram-positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula (I), wherein R 4 is selected from the group consisting of H, (a), OR 4 5, -R 6 6 C (O) H , -R 6 6 OH, -R 6 6 COOH, -OR 6 6 OH, -OR 6 6 COOH, -C (O) NH 2 -, formula (1) and NH 2 - and salts the same; R 5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R 8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with heteroatoms; R 2, R 3 and R 4 are independently selected from the group consisting of H, OH, COOH, and -C (O) R 9; R 9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.

BR0212679-6A 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions BR0212679A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
PCT/US2002/028756 WO2003030953A1 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Publications (1)

Publication Number Publication Date
BR0212679A true BR0212679A (en) 2005-04-12

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212679-6A BR0212679A (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Country Status (9)

Country Link
EP (1) EP1432459A1 (en)
JP (1) JP2005523239A (en)
KR (1) KR100918887B1 (en)
AR (1) AR037505A1 (en)
AU (1) AU2002336472B2 (en)
BR (1) BR0212679A (en)
CA (1) CA2461291A1 (en)
MX (1) MXPA04002474A (en)
WO (1) WO2003030953A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (en) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molecule for the functionalization of a carrier, binding of a radionuclide to the carrier and radionuclide generator for the production of the radionuclide and production method
JP2017536893A (en) * 2014-11-27 2017-12-14 イェディテペ・ウニヴェルシテシＹｅｄｉｔｅｐｅ Ｕｎｉｖｅｒｓｉｔｅｓｉ Antibacterial and antiviral hygiene products
EP3520785A4 (en) * 2016-10-09 2020-05-27 Shenzhen Eulikan Biotechnology Co., Ltd. Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (en) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC TAMPONS WITH HIGH ACTIVE SUBSTANCE RELEASE
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (en) * 1994-04-05 1995-10-12 Beiersdorf Ag Novel deodorant and antimicrobial compositions for use in cosmetic or topical preparations
JPH07289575A (en) * 1994-04-27 1995-11-07 Okamoto Ind Inc Rerfume-added condom and method for adding perfume to condom
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (en) * 1994-09-29 1996-04-04 Beiersdorf Ag Use of fatty acid esters to combat superinfections
DE69623485T2 (en) * 1995-06-07 2003-01-09 Kimberly Clark Co INHIBITATION OF EXOPROTEIN IN ABSORBENT PRODUCTS
JPH09108257A (en) * 1995-10-23 1997-04-28 Shiyouichi Masugi Luminous cream and latex condom
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
CA2266070A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
CA2287451C (en) * 1997-04-18 2014-06-10 Sean Farmer Topical use of probiotic bacillus spores to prevent or control microbial infections
KR20010013377A (en) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
KR20010034361A (en) * 1998-01-28 2001-04-25 데이비드 엠 모이어 Antimicrobial hydrogel forming absorbent polymers
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
BR9910784A (en) * 1998-05-29 2002-01-29 Kimberly Clark Co Smell reduction device

Also Published As

Publication number Publication date
CA2461291A1 (en) 2003-04-17
EP1432459A1 (en) 2004-06-30
MXPA04002474A (en) 2004-05-31
KR100918887B1 (en) 2009-09-23
AU2002336472B2 (en) 2007-08-23
KR20040044950A (en) 2004-05-31
AR037505A1 (en) 2004-11-17
WO2003030953A1 (en) 2003-04-17
JP2005523239A (en) 2005-08-04

Similar Documents

Publication Publication Date Title
BR0109851A (en) Compound, method for producing the same or a salt thereof, prodrug, pharmaceutical composition, method for inhibiting tyrosine kinase, method for preventing or treating cancer, and use of a compound or salt or prodrug thereof
BR0010555A (en) Neuraminidase Inhibitors
PT1254144E (en) NEW PHOSPHORUS COMPOUNDS
BR0014075A (en) Kinase inhibitors as therapeutic agents
BR0213960A (en) Treatment of Acute Myloid Leukemia with Indolinone Compounds
BR0214096A (en) Pde9 inhibitors for the treatment of cardiovascular disorders
BRPI0906495B8 (en) indolyl-pyridone derivative compounds and pharmaceutical composition
BR0116468A (en) Indazolyl-substituted pyrroline compounds as kinase inhibitors
BR9913654A (en) P-38alpha kinase inhibitors
ES2169871T3 (en) EMPLOYMENT OF POLIACIDES FOR THE TREATMENT OF MINERAL FERTILIZERS CONTAINING A NITRIFIED INHIBITOR.
BR9910122A (en) Amidine compounds
BRPI0510059A (en) non-nucleoside reverse transcriptase inhibitors
WO2005089256A3 (en) Antiangiogenic agents
WO2008006718A3 (en) Synergistic anti-microbial mixtures of tropolone (derivatives) and selected compounds
ATE301460T1 (en) PREPARATION FOR THE PROPHYLAXIS OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF A PLANT OF THE GENUS ANGELICA CONTAINING SUCH ACID.
GB1392044A (en) Corrosion inhibiting composition
MX173955B (en) DEODORATING COMPOSITION CONTAINING AMINO ACID BETA-LIASA ENZYME INHIBITORS
BR0212679A (en) Inhibition of exoprotein production using aromatic compositions
BR0014615A (en) Derived from phosphonic acid which has inhibitory activity against carboxypeptidase b
CA2022187A1 (en) N,n-bis-phosphonomethyl taurine n-oxide and water-soluble salts thereof
ES2116313T3 (en) COMPOSITION AND METHOD FOR INHIBITING INCRUSTATIONS AND CORROSION USING NAFTILAMINO-POLYCARBOXYLIC ACIDS.
ATE172749T1 (en) DETERGENT COMPOSITIONS FOR PREVENTING DYE TRANSFER
BR0006299A (en) Derivatives of 4-oxo-2-urea-1,4,5,6-tetrahydro-pyrimidine
MXPA02012481A (en) Benzoxazepinones and their use as squalene synthase inhibitors.
BR9910206A (en) Hygromycin derivatives a.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.